Cargando…

Opposite effects of angiotensins receptors type 2 and type 4 on streptozotocin induced diabetes vascular alterations in mice

BACKGROUND: We examined the effect of chronic administration of angiotensin IV (AngIV) on the vascular alterations induced by type 1 diabetes in mice. METHODS: Diabetes was induced in adult Swiss mice with a single injection of streptozotocin (STZ). Mice were treated subcutaneously with AngIV (1.4 m...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nasser, Mohamad, Clere, Nicolas, Botelle, Laurent, Javellaud, James, Oudart, Nicole, Faure, Sébastien, Achard, Jean-Michel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Original Investigation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3931492/ https://www.ncbi.nlm.nih.gov/pubmed/24511993 http://dx.doi.org/10.1186/1475-2840-13-40

Ejemplares similares

Candesartan restores pressure-induced vasodilation and prevents skin pressure ulcer formation in diabetic mice
por: Danigo, Aurore, et al.
Publicado: (2015)

Angiotensin Converting Enzyme and Angiotensin II Type 1 Receptor Polymorphisms in Patients with Coronary Aneurysms
por: Lamblin, Nicolas, et al.
Publicado: (2003)

Vaccination against type 1 angiotensin receptor prevents streptozotocin-induced diabetic nephropathy
por: Ding, Dan, et al.
Publicado: (2015)

Losartan counteracts the hyper-reactivity to angiotensin II and ROCK1 over-activation in aortas isolated from streptozotocin-injected diabetic rats
por: Failli, Paola, et al.
Publicado: (2009)

Type I and type III interferon in opposition?
por: Park, Matthew D.
Publicado: (2020)

Humans and Chimpanzees Display Opposite Patterns of Diversity in Arylamine N-Acetyltransferase Genes
por: Vangenot, Christelle, et al.
Publicado: (2019)

Angiotensin type 1a receptor-deficient mice develop diabetes-induced cardiac dysfunction, which is prevented by renin-angiotensin system inhibitors
por: Yong, Qian Chen, et al.
Publicado: (2013)

Cardiac metabolism in a new rat model of type 2 diabetes using high-fat diet with low dose streptozotocin
por: Mansor, Latt S, et al.
Publicado: (2013)

Caffeic acid phenethyl amide improves glucose homeostasis and attenuates the progression of vascular dysfunction in Streptozotocin-induced diabetic rats
por: Ho, Yi-Jin, et al.
Publicado: (2013)

Vascular calcification in patients with type 2 diabetes: the involvement of matrix Gla protein
por: Liabeuf, Sophie, et al.
Publicado: (2014)

Opposite Expression of SPARC between the Liver and Pancreas in Streptozotocin-Induced Diabetic Rats
por: Aseer, Kanikkai Raja, et al.
Publicado: (2015)

Comparative effect of angiotensin II type I receptor blockers and calcium channel blockers on laboratory parameters in hypertensive patients with type 2 diabetes
por: Nishida, Yayoi, et al.
Publicado: (2012)

Angiotensin II type 1 and type 2 receptor expression in circulating monocytes of diabetic and hypercholesterolemic patients over 3-month rosuvastatin treatment
por: Marino, Franca, et al.
Publicado: (2012)

Alterations of specific biomarkers of metabolic pathways in vascular tree from patients with Type 2 diabetes
por: Rosa, Bernal-Lopez M, et al.
Publicado: (2012)

Endothelial-to-Mesenchymal Transition (EndoMT): Roles in Tumorigenesis, Metastatic Extravasation and Therapy Resistance
por: Platel, Valentin, et al.
Publicado: (2019)

Determinants of vascular function in patients with type 2 diabetes
por: Naka, Katerina K, et al.
Publicado: (2012)

Association of Angiotensin II Type 1 Receptor Agonistic Autoantibodies With Outcomes in Patients With Acute Aortic Dissection
por: Wu, Xiao-wei, et al.
Publicado: (2021)

Association of Antihypertensives That Stimulate vs Inhibit Types 2 and 4 Angiotensin II Receptors With Cognitive Impairment
por: Marcum, Zachary A., et al.
Publicado: (2022)

Duration of streptozotocin-induced diabetes differentially affects p38-mitogen-activated protein kinase (MAPK) phosphorylation in renal and vascular dysfunction
por: Chen, Hongmei, et al.
Publicado: (2005)

Comparative vascular responses three months after paclitaxel and everolimus-eluting stent implantation in streptozotocin-induced diabetic porcine coronary arteries
por: Sheehy, Alexander, et al.
Publicado: (2012)

Opposite effects on facial morphology due to gene dosage sensitivity
por: Hammond, Peter, et al.
Publicado: (2014)

Myocardial performance in conscious streptozotocin diabetic rats
por: Borges, Giulianna R, et al.
Publicado: (2006)

Analysis of renin-angiotensin aldosterone system gene polymorphisms in malaysian essential hypertensive and type 2 diabetic subjects
por: Ramachandran, Vasudevan, et al.
Publicado: (2009)

Early vascular parameters in the micro- and macrocirculation in type 2 diabetes
por: Kannenkeril, Dennis, et al.
Publicado: (2018)

Comparative effect of angiotensin II type I receptor blockers on serum uric acid in hypertensive patients with type 2 diabetes mellitus: a retrospective observational study
por: Nishida, Yayoi, et al.
Publicado: (2013)

Azilsartan, an angiotensin II type 1 receptor blocker, restores endothelial function by reducing vascular inflammation and by increasing the phosphorylation ratio Ser(1177)/Thr(497) of endothelial nitric oxide synthase in diabetic mice
por: Matsumoto, Sachiko, et al.
Publicado: (2014)

Association of serum osteoprotegerin with vascular calcification in patients with type 2 diabetes
por: Aoki, Atsushi, et al.
Publicado: (2013)

Epigallocatechin Gallate: A Review of Its Beneficial Properties to Prevent Metabolic Syndrome
por: Legeay, Samuel, et al.
Publicado: (2015)

Metformin treatment improves vascular function in rats with neonatal streptozotocin-induced type 2 diabetes
por: Sartoretto, JL, et al.
Publicado: (2003)

SGLT2 inhibition via dapagliflozin improves generalized vascular dysfunction and alters the gut microbiota in type 2 diabetic mice
por: Lee, Dustin M., et al.
Publicado: (2018)

Cardio-protective effects of carnitine in streptozotocin-induced diabetic rats
por: Malone, John I, et al.
Publicado: (2006)

Effect of vitamin D on aortic remodeling in streptozotocin-induced diabetes
por: Salum, Erik, et al.
Publicado: (2012)

Leptin is associated with vascular endothelial function in overweight patients with type 2 diabetes
por: Morioka, Tomoaki, et al.
Publicado: (2014)

Effects of exenatide on postprandial vascular endothelial dysfunction in type 2 diabetes mellitus
por: Torimoto, Keiichi, et al.
Publicado: (2015)

Chromatin Signature Identifies Monoallelic Gene Expression Across Mammalian Cell Types
por: Nag, Anwesha, et al.
Publicado: (2015)

Effects of Angiotensin Receptor Blockers on Streptozotocin-Induced Diabetic Cataracts
por: Ishigooka, Gaku, et al.
Publicado: (2023)

Association of New Use of Antihypertensives That Stimulate vs Inhibit Type 2 and 4 Angiotensin II Receptors With Dementia Among Medicare Beneficiaries
por: Marcum, Zachary A., et al.
Publicado: (2023)

Nestin downregulation in rat vascular smooth muscle cells represents an early marker of vascular disease in experimental type I diabetes
por: Tardif, Kim, et al.
Publicado: (2014)

Heroin versus cocaine: opposite choice as a function of context but not of drug history in the rat
por: De Luca, Maria Teresa, et al.
Publicado: (2018)

Intracellular Ca(2+ )regulating proteins in vascular smooth muscle cells are altered with type 1 diabetes due to the direct effects of hyperglycemia
por: Searls, Yvonne M, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_getn21na9ru8fqjtbpcqmc9csc